Fireside chat Regulatory Strategy track
From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling
Wed, Nov 11, 2026 · 9:00–9:45 AM CET Regulatory Strategy Stage, Koelnmesse
About this session
Examine how NAMs can help accelerate drug discovery, streamlining development timelines, and open new pathways for regulatory decision-making. Understand the current NAMs landscape and the role of NAMs in reshaping biomedical innovation.Explore the European funding opportunities for driving human-relevant modelling: from organ-on-chip platforms to AI-enabled digital twins.Steps for regulatory acceptance: understanding the principles of a well-defined context of use, the evidence required to demonstrate fitness for purpose and available routes for regulatory interaction, from early advice and…
